Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism

Z. Minarikova, L. Gaspar, P. Kruzliak, Z. Celecová, S. Oravec,

. 2014 ; 13 (-) : 158.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15014028

BACKGROUND: Atherogenic dyslipoproteinemia is one of the most important risk factor for atherosclerotic changes development. Hypothyroidism is one of the most common causes of secondary dyslipidemias which results from reduced LDL clearance and therefore raised levels of LDL and apoB. Association between small dense LDL (sdLDL) presentation and thyroid status has been examinated using polyacrylamide gel electrophoresis for lipoprotein subfractions evaluation. METHODS: 40 patients with diagnosed autoimmune hypothyroidism and 30 patients with autoimmune hyperthyroidism were treated with thyroxine replacement or thyreo-suppressive treatment. In both groups lipid profiles, LDL subractions, apolipoproteins (apoA1, apoB), apoA1/apoB ratio and atherogenic index of plazma (AIP) were examined before treatment and in state of euthyreosis. RESULTS: Thyroxine replacement therapy significantly reduced levels of total cholesterol (TC), LDL, triglycerides (TG) and also decreased levels of sdLDL (8,55±11,671 vs 0,83±1,693mg/dl; p<0,001), apoB and AIP. For estimation of atherogenic lipoprotein profile existence an AIP evaluation seems to be better than apoB measurement because of the more evident relationship with sdLDL (r=0,538; p<0,01). Thyreo-suppressive therapy significantly increased levels of TC, LDL, TG and apoB. The sdLDL was not found in hyperthyroid patients. CONCLUSIONS: Atherogenic lipoprotein profile was present in 52.5% of hypothyroid subjects, which is higher prevalence than in normal, age-related population. Substitution treatment leads to an improvement of the lipid levels, TG, apoB, AIP and LDL subclasses. It significantly changed the presentation of sdLDL - we noticed shift to large, less atherogenic LDL particles. Significantly positive correlation between sdLDL and TAG; sdLDL and VLDL alerts to hypertriglyceridemia as a major cardiovascular risk factor.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014028
003      
CZ-PrNML
005      
20150428105250.0
007      
ta
008      
150420s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/1476-511X-13-158 $2 doi
035    __
$a (PubMed)25300222
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Minarikova, Zuzana
245    14
$a The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism / $c Z. Minarikova, L. Gaspar, P. Kruzliak, Z. Celecová, S. Oravec,
520    9_
$a BACKGROUND: Atherogenic dyslipoproteinemia is one of the most important risk factor for atherosclerotic changes development. Hypothyroidism is one of the most common causes of secondary dyslipidemias which results from reduced LDL clearance and therefore raised levels of LDL and apoB. Association between small dense LDL (sdLDL) presentation and thyroid status has been examinated using polyacrylamide gel electrophoresis for lipoprotein subfractions evaluation. METHODS: 40 patients with diagnosed autoimmune hypothyroidism and 30 patients with autoimmune hyperthyroidism were treated with thyroxine replacement or thyreo-suppressive treatment. In both groups lipid profiles, LDL subractions, apolipoproteins (apoA1, apoB), apoA1/apoB ratio and atherogenic index of plazma (AIP) were examined before treatment and in state of euthyreosis. RESULTS: Thyroxine replacement therapy significantly reduced levels of total cholesterol (TC), LDL, triglycerides (TG) and also decreased levels of sdLDL (8,55±11,671 vs 0,83±1,693mg/dl; p<0,001), apoB and AIP. For estimation of atherogenic lipoprotein profile existence an AIP evaluation seems to be better than apoB measurement because of the more evident relationship with sdLDL (r=0,538; p<0,01). Thyreo-suppressive therapy significantly increased levels of TC, LDL, TG and apoB. The sdLDL was not found in hyperthyroid patients. CONCLUSIONS: Atherogenic lipoprotein profile was present in 52.5% of hypothyroid subjects, which is higher prevalence than in normal, age-related population. Substitution treatment leads to an improvement of the lipid levels, TG, apoB, AIP and LDL subclasses. It significantly changed the presentation of sdLDL - we noticed shift to large, less atherogenic LDL particles. Significantly positive correlation between sdLDL and TAG; sdLDL and VLDL alerts to hypertriglyceridemia as a major cardiovascular risk factor.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a thyreostatika $x terapeutické užití $7 D013956
650    _2
$a apolipoprotein A-I $x krev $x izolace a purifikace $7 D016632
650    _2
$a apolipoprotein B-100 $x krev $x izolace a purifikace $7 D053299
650    _2
$a LDL-cholesterol $x krev $x izolace a purifikace $7 D008078
650    _2
$a elektroforéza v polyakrylamidovém gelu $7 D004591
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a Hashimotova nemoc $x krev $x farmakoterapie $7 D050031
650    _2
$a lidé $7 D006801
650    _2
$a hypertyreóza $x krev $x farmakoterapie $7 D006980
650    _2
$a lipoproteiny VLDL $x krev $x izolace a purifikace $7 D008079
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methimazol $x terapeutické užití $7 D008713
650    _2
$a lidé středního věku $7 D008875
650    _2
$a thyroxin $x terapeutické užití $7 D013974
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Gaspar, Ludovit
700    1_
$a Kruzliak, Peter $u Department of Cardiovascular Diseases, International Clinical Research Center, St, Anne's University Hospital and Masaryk University, Pekarska 53, Brno 656 91, Czech Republic. peter.kruzliak@savba.sk.
700    1_
$a Celecová, Zuzana
700    1_
$a Oravec, Stanislav
773    0_
$w MED00008241 $t Lipids in health and disease $x 1476-511X $g Roč. 13, č. - (2014), s. 158
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25300222 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20150428105550 $b ABA008
999    __
$a ok $b bmc $g 1071609 $s 896906
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 13 $c - $d 158 $i 1476-511X $m Lipids in health and disease $n Lipids Health Dis $x MED00008241
LZP    __
$a Pubmed-20150420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...